Nitric oxide synthase inhibitor, aminoguanidine, reduces inflammation and demyelination produced by Theiler's virus infection

Journal of Neuroimmunology

Volumn 81, Issue 1-2, 1998, Pages 82-89

  Rose, John W ^a,b   Hill, Kenneth E ^a   Wada, Yoshiaki ^b   Kurtz, Caroline I B ^b   Tsunoda, Ikuo ^b   S Fujinami, Robert ^b   Cross, Anne H ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c NONE

Author keywords

Aminoguanidine; Apoptosis; Nitric oxide synthase; Theiler's murine encephalomyelitis virus

Indexed keywords

AMINOGUANIDINE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; DEMYELINATION; FEMALE; IMMUNOPATHOLOGY; MOUSE; MURINE ENCEPHALOMYELITIS VIRUS; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; VIRUS ENCEPHALITIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; AXONS; DEMYELINATING DISEASES; DNA FRAGMENTATION; ENZYME INHIBITORS; FEMALE; GUANIDINES; MICE; NECROSIS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; POLIOMYELITIS; SINGLE-BLIND METHOD; SPINAL CORD; THEILOVIRUS;

EID: 0031809195     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00162-8     Document Type: Article

References (58)

1. Belenky S., Robbins R., Rubinstein I. Nitric oxide synthase inhibitors attenuate human monocyte chemotaxis in vitro. J. Leuk. Biol. 53:1993;503-598.
2. Billiar T., Curran R., Harbrecht B., Stadler J.et al. Association between synthesis and release of cGMP and nitric oxide biosynthesis by hepatocytes. Am. J. Physiol. 262:1992;C10077-C1082.
3. Bo L., Dawson T., Wesselingh S., Mork S., Choi S., Kong P., Hanley D., Trapp B. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann. Neurol. 36:1994;778-786.
4. Bogdan C., Vodovotz Y., Paik J., Xie Q., Nathan C. Mechanism of suppression of nitric oxide synthase expression by interleukin-4 in primary mouse macrophages. J. Leuk. Biol. 55:1994;227-233.
5. Brahic M., Stroop W., Baringer R. Theiler's virus persists in glial cells during demyelinating disease. Cell. 26:1981;123-128.
6. Bredt D., Snyder S. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. Natl. Acad. Sci. USA. 86:1989;9030-9033.
7. Brosnan C., Battistini L., Raine C., Dickson D., Casadevall A., Lee S. Reactive nitrogen intermediates in human neuropathology: an overview. Dev. Neurosci. 16:1994;152-161.
8. Clatch R., Miller S., Metzner R., Dal Canto M., Lipton H. Monocytes/macrophages isolated from the mouse central nervous system contain infectious Theiler's murine encephalomyelitis virus (TMEV). Virology. 176:1990;244-254.
9. Cohen J. Overview: mechanisms of apoptosis. Immunology Today. 14:1993;126-130.
10. Connor J., Manning P., Settle S., Moore W., Jerome G., Webber R., Tjoeng F., Currie M. Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase. Eur. J. Pharmacol. 273:1995;15-24.
11. Cross A., Misko T., Lin R., Hickey W., Trotter J., Tilton R. Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J. Clin. Invest. 93:1994;2684-2690.
12. Cross A., Keeling R., Goorha S., San M., Rodi C., Wyatt P., Manning P., Misko T. Inducible nitric oxide synthase gene expression and enzyme activity correlate with disease activity in murine experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 71:1996;143-145.
13. Cuhna F., Moncada S., Liew F. IL-10 inhibits the induction of nitric oxide synthase by IFN gamma in murine macrophages. Biochem. Biophys. Res. Comm. 182:1992;1155-1159.
14. Dawson, V., Dawson, T., 1995. Physiological and toxicological actions of nitric oxide in the central nervous system. In: Ignarro, L., Murad, F. (Eds.), Nitric Oxide: biochemistry, molecular biology, and therapeutic implications. Academic Press, San Diego.
15. Ding A., Nathan C., Stuehr D. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J. Immunol. 141:1988;2407-2412.
16. Gravrieli Y., Sherman Y., Ben-Sasson S. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 113:1992;493-501.
17. Hausladen A., Fridovich I. Superoxide and peroxynitrite inactivates aconitases, but nitric oxide does not. J. Biol. Chem. 269:1994;29405-29408.
18. Ianaro A., O'Donnell C., DiRosa M., Liew F. A nitric oxide synthase inhibitor reduces inflammation and down-regulates inflammatory cytokines and enhances interleukin-10 production in caarageenin-induced oedema in mice. Immunology. 82:1994;370-375.
19. Kaplan S., Billar T., Curran R., Zdziarske U., Simmons R., Basford R. Inhibition of chemotaxis with NG-monomethyl-L-arginine: a role for cyclic GMP. Blood. 74:1989;763-771.
20. Koprowski H., Zheng Y., Heber-Katz E., Fraser N., Rorke L., Fu Z., Hanlon C., Dietzschold B. In vivo expression of inducible nitric oxide synthase in experimentally induced neurological diseases. Proc. Natl. Acad. Sci. USA. 90:1993;3024-3027.
21. Lipton H., Dal Canto M. Susceptibility of inbred mice to chronic central nervous system infection by Theiler"s murine encephalomyelitis virus. Infection and Immunity. 26:1979;369-374.
22. Lipton, H., 1995. Theiler's murine encephalomyelitis virus: animal models. In: Stroop, W., Mckendall, R. (Eds.), Handbook of Neurovirology, ch. 39, pp. 521-528.
23. Lipton S., Choi Y.-B., Pan Z.-H., Lei S., Chen H.-S., Sucher N., Loscalzo J., Singel D., Stamler J. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature. 364:1993;626-632.
24. Lucchinetti C., Bruck W., Rodriquez M., Lassmann H. Distinct patterns of multiple sclerosis pathology indicate heterogeneity in pathogenesis. Brain Pathology. 6:1996;259-274.
25. Mackenzie-Graham A., Mitrovic B., Smoll A., Merrill J. Differential sensitivity to nitric oxide in immortalized, cloned murine oligodendrocyte cell lines. Dev. Neurosci. 16:1994;162-171.
26. MacMicking J., Willenborg D., Weidmann M., Rockett K., Cowden W. Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: enhancement by soluble products of encephalitogenic T cells. J. Exp. Med. 176:1992;303-307.
27. McCarthy-Francis N., Allen J., Mizel D., Albina J., Xie Q., Nathan C., Wahl S. Suppression of arthritis by an inhibitor of nitric oxide synthase. J. Exp. Med. 178:1993;749-754.
28. Merrill, J., Murphy, S., 1995. Nitric Oxide. In: Aschner, M., Kimelberg, H. (Eds.), The Role of Glia in Neurotoxicity. CRC Press, Boca Raton.
29. Merrill J., Ignarro L., Sherman M., Melinek J., Lane T. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151:1993;2132-2141.
30. Miller S., Gerety S. Immunologic aspects of Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. Semin. Virol. 1:1990;263-272.
31. Miller S., McRae B., Vanderlugt C., Nikcevich K., Pope J., Pope L., Karpus W. Evolution of the T-cell repertoire during the course of experimental immune-mediated demyelinating diseases. Imm. Rev. 144:1995;226-244.
32. Misko T., Moore W., Kasten T., Nickols G., Corbett J., Tilton R., Mcdaniel M., Williamson J., Currie M. Selective inhibition of inducible nitric oxide synthase by aminoguanidine. Eur. J. Pharm. 233:1992;119-122.
33. Mitrovic B., Ignarro L., Montesrtuque S., Smoll A., Merrill J. Nitric oxide as a potential pathologic mechanism in demyelination: its differential effects on primary glial cells in vitro. Neuroscience. 61:1994;575-585.
34. Mitrovic B., Ignarro L., Vinters H., Akers M., Schmid I., Uittengogaart C., Merrill J. Nitric oxide induces necrotic but nor apoptotic cell death in oligodendrocytes. Neuroscience. 65:1995;531-539.
35. Moore G., Traugott U., Farooq M., Raine C. Experimental autoimmune encephalomyelitis. Augmentation of demyelination by different myelin lipids. Lab. Invest. 51:1984;416-424.
36. Murphy S., Simmons M., Agullo L., Garcia A.et al. Synthesis of nitric oxide in CNS glial cells. Trends in Neurosci. 16:1993;323-328.
37. Nathan C., Hibbs J. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3:1991;65-70.
38. Nussler A., Billiar T. Inflammation, immunoregulation, and inducible nitric oxide synthase. J. Leukoc. Biol. 54:1993;171-178.
39. Olsson T. Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Imm. Rev. 144:1995;245-268.
40. Ozawa K., Suchanek G., Breitsschopf H., Bruck W., Jellinger K., Lassmann H. Patterns of oligodenroglia pathology in multiple sclerosis. Brain. 117:1994;1311-1322.
41. Pelfry C., Tranquill L., Boehme S., McFarland H., Lenardo M. Two basic mechanisms of antigen-specific apoptosis of myelin basic protein (MBP)-specific T lymphocytes derived from multiple sclerosis patients and normal individuals. J. Immunol. 154:1995;6191-6202.
42. Powrie F., Menon S., Coffman R. Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. Eur. J. Immunol. 23:1993;3043-3049.
43. Racke M., Bonomo A., Scott D., Cannella B., Levine A., Raine C., Shevach E., Rocken M. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 180:1994;1961-1967.
44. Rodriguez M., Leibowitz J., Lampert P. Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis. Ann. Neurol. 13:1983;426-433.
45. Roth M., Keul R., Emmons L., Horl W., Block I. Manidipine regulates the transcription of cytokine genes. Proc. Natl. Acad. Sci. USA. 89:1992;4041-4045.
46. Salvemini D., Manning P., Zweifel B., Seibert K., Connor J., Currie M., Needleman P., Masferrer J. Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors. J. Clin. Invest. 96:1995;301-308.
47. Sicher S., Vazquez M., Lu C. Inhibition of Ia expression by nitric oxide. J. Immunol. 153:1994;1293-1300.
48. Simmons M., Murphy S. Cytokines regulate L-arginine-dependent cyclic GMP production in rat glial cells. Eur. J. Neurosci. 5:1993;825-831.
49. Szabo C., Thiemermann C., Vane J. Dihydropyridine antagonists and agonist of calcium channels inhibit the induction of nitric oxide synthase by endotoxin in cultured macrophages. Biochem. Biophys. Res. Comm. 196:1993;825-830.
50. Szabo C., Mitchell J., Gross S., Thiermann C., Vane J. Nifedipine inhibits the induction of nitric oxide synthase by bacterial liposaccharide. J. Pharm. Exp. Ther. 265:1993;674-680.
51. Szabo C., Southan G., Thiermann C. Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc. Natl. Acad. Sci. USA. 91:1994;12472-12476.
52. Szabo C., Thiermann C., Flower R., Vane J. Effect of interleukin 4 on interleukin 1-induced neutrophil migration and on endotoxin-induced nitric oxide production in macrophages and neutrophils. Br. J. Pharmacol. 112:1994;519.
53. Tsunoda I., Kurtz C., Fujinami R. Apoptosis in acute and chronic central nervous system disease induced by Theiler's murine encephalomyelitis virus. Virology. 228:1997;388-393.
54. Wei X., Charles I., Smith A., Ure J., Feng G., Huang F., Xu D., Muller W., Mocada S., Liew F. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature. 375:1995;408-411.
55. G-monomethyl-L-arginine. J. Exp. Med. 179:1994;651-660.
56. Wolff D., Lubeskie A. Aminoguanidine is an isoform-selective, mechanism-based inactivator of nitric oxide synthase. Arch. Biochem. Biophys. 316:1995;290-301.
57. Wong, J., Billiar, T., 1995. Regulation and function of inducible nitric oxide synthase during sepsis and acute inflammation. In: Ignarro, L., Murad, F. (Eds.), Nitric Oxide: biochemistry, molecular biology, and therapeutic implications. Academic Press, San Diego.
58. Zingarelli B., O'Connor M., Wong H., Salzman A., Szabo C. Peroxynitrite-mediated DNA strand breakage activates poly-adenosine diphosphate ribosyl synthetase and causes cellular energy depletion in macrophages stimulated with bacterial lipopolysaccharide. J. Immunol. 156:1996;350-358.